GenMark Diagnostics, Inc. company info

CIK 1487371
IRS Number 272053069
State of incorporation DE
Business address 5964 LA PLACE COURT
Mail address 5964 LA PLACE COURT

Short summary

GenMark Diagnostics, Inc. is a California company, with head office located at 5964 La Place Court Carlsbad, California 92008. In 2018 the company owned a total of 91.03 million USD worth of assets, including 65.67 million USD worth of current assets. 2016 was the year when the company amassed the most assets.

GenMark Diagnostics, Inc. Income Statement

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Gross Profit -3.33-1.42-1.208.8311.8317.4724.0929.5720.01
Research and development 5.636.658.7413.5422.0631.8237.4749.4642.76
Operating Expenses 17.1118.6222.6730.7246.3956.5265.6378.5679.52
Operating Income (Loss) -20.44-20.03-23.86-21.89-34.88-39.05-41.54-48.98-59.52
Interest expense
Other Nonoperating Income (Expense) 0.01-0.020.90-0.010.13-0.160.25
Income Tax Expense (Benefit) -
Net income -19.96-18.40-23.97-22.10-33.64-38.26-42.20-50.60-61.85

GenMark Diagnostics, Inc. Balance Sheet

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Cash and cash equivalents 8.8229.6043.5264.2218.8426.8332.0829.5688.4328.8925.01
Accounts Receivable, Net, Current 0.641.294.432.133.565.427.277.149.86
Inventories 1.211.883.431.151.972.617.118.8311.25
Property, Plant and Equipment, Gross 9.5514.6917.4420.8724.5935.2840.8642.83
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 5.376.647.499.0411.9415.5119.7020.96
Intangible Assets, Net (Excluding Goodwill) 1.401.672.592.001.742.192.922.332.17
Other Assets, Noncurrent
Total assets 50.5473.5456.87106.6483.6262.62145.8597.9091.03
Current assets 45.8667.5845.1393.8369.1246.85122.2273.1365.67
Accounts payable 2.871.572.
Standard Product Warranty Accrual 0.250.440.38
Total current liabilities 6.656.737.7011.709.2915.8834.0035.8117.53
Long-term Debt, Excluding Current Maturities 9.7016.7414.909.5828.73
Long-term Debt 0.349.3519.6619.959.92
Total liabilities 8.817.6910.0413.9720.6034.1852.5048.2549.33
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -156.72-179.62-202.76-244.20-284.49-330.54-387.18-444.33-455.32
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.510.44-0.450.00-

GenMark Diagnostics, Inc. Cash Flow

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Net income -19.96-18.40-23.97-22.10-33.64-38.26-42.20-50.60-61.85
Amortization of Intangible Assets
Depreciation and amortization 1.571.061.331.202.532.663.413.925.32
Deferred Income Tax Expense (Benefit) 00-0.010.01
Accounts receivable 0.050.510.422.072.392.031.982.251.56
Inventories -1.230.651.74-0.881.310.231.293.4510.51
Accounts payable -0.86-1.060.380.731.340.09-0.764.112.56
Net Cash Provided by (Used in) Operating Activities -15.44-18.86-19.21-16.24-23.80-29.57-31.92-35.64-53.42
Payments to Acquire Property, Plant, and Equipment 1.071.861.383.484.275.733.7674.82
Payments to Acquire Intangible Assets 0.731.330.880.350.551.500.50
Net Cash Provided by (Used in) Investing Activities -1.06-1.86-7.11-2.15-72.5629.4219.32-24.12-24.91
Proceeds from Issuance of Long-term Debt 101015
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures -
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures -
Proceeds from Issuance of Common Stock 24.1327.6034.5348.3086.550.810.8830.9287.27
Net Cash Provided by (Used in) Financing Activities 24.1322.6133.2644.3280.831.2911.1340.3689.05
Cash and Cash Equivalents, Period Increase (Decrease) 7.661.856.9925.93-15.531.13-1.47-19.4310.80